Veradigm Inc. (MDRX)
OTCMKTS · Delayed Price · Currency is USD
4.910
+0.010 (0.20%)
Jan 27, 2026, 4:00 PM EST
Veradigm Revenue
In the year 2022, Veradigm had annual revenue of $588.02M with 1.83% growth. Veradigm had revenue of $151.92M in the quarter ending September 30, 2022, with 5.01% growth.
Revenue
588.02M
Revenue Growth
+1.83%
P/S Ratio
1.42
Revenue / Employee
240.01K
Employees
2,450
Market Cap
834.76M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 588.02M | 10.59M | 1.83% |
| Dec 31, 2021 | 577.43M | 21.31M | 3.83% |
| Dec 31, 2020 | 556.12M | -1.08B | -65.94% |
| Dec 31, 2019 | 1.63B | 14.77M | 0.91% |
| Dec 31, 2018 | 1.62B | 120.13M | 8.02% |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vaso Corporation | 89.11M |
| Veri Medtech Holdings | 11.89M |
| Pharma-Bio Serv | 9.18M |
| CareView Communications | 8.82M |
| DATATRAK International | 6.50M |
| BioRegenx | 1.93M |
| CompuMed | 1.69M |
| Resilient Healthcare | 1.21M |
Veradigm News
- 13 days ago - Veradigm and Meperia Launch Industry-First 8-Way Match EDI Platform to Strengthen Healthcare Supply Chain Integrity - Business Wire
- 2 months ago - Veradigm Launches Enhanced Ambient Scribe Capabilities - Business Wire
- 2 months ago - Veradigm Adds Sentara Health Plans to Veradigm Payer Insights Solution - Business Wire
- 3 months ago - Veradigm Appoints Tehsin Syed as Chief Product and Technology Officer - Business Wire
- 4 months ago - Veradigm Inc. (MDRX) Investor Update Call (Transcript) - Seeking Alpha
- 4 months ago - Veradigm Inc. - Special Call - Seeking Alpha
- 4 months ago - Veradigm Inc (MDRX) Q2 2025 Earnings: Revenue Falls Short at $145-$148 Million, Cash Reserves ... - GuruFocus
- 4 months ago - Veradigm Provides 2025 Business Update - Business Wire